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Abstract
Background: General iron-sulfur cluster biosynthesis proceeds through assembly of a transient cluster on IscU
followed by its transfer to a recipient apo-protein. The efficiency of the second step is increased by the presence
of HscA and HscB, but the reason behind this is poorly understood. To shed light on the function of HscB, we
began a study on the nature of its interaction with IscU. Our work suggested that the binding site of IscU is in the
C-terminal domain of HscB, and two different triple alanine substitutions ([L92A, M93A, F153A] and [E97A, E100A,
E104A]) involving predicted binding site residues had detrimental effects on this interaction. However, the
individual contribution of each substitution to the observed effect remains to be determined as well as the
possible involvement of other residues in the proposed binding site.
Results: In the work reported here, we used isothermal titration calorimetry to characterize the affinity of single
alanine HscB mutants for IscU, and subsequently confirmed our results with nuclear magnetic resonance
spectroscopy. Alanine substitutions of L92, L96, and F153 severely impaired the ability of HscB to form a complex
with IscU; substitutions of R87, R99, and E100 had more modest effects; and substitutions of T89, M93, E97, D103,
E104, R152, K156, and S160 had only minor or no detectable effects.
Conclusions: Our results show that the residues of HscB most important for strong interaction with IscU include
three hydrophobic residues (L92, L96, and F153); in addition, we identified a number of other residues whose side
chains contribute to a lesser extent to the interaction. Our results suggest that the triple alanine substitution at
HscB positions 92, 96, and 153 will destabilize the HscB-IscU complex by ΔΔGb ≅ 5.7 kcal/mol, equivalent to a ≅
15000-fold reduction in the affinity of HscB for IscU. We propose that this triple mutant could provide a more
definitive test of the functional importance of the HscB-IscU interaction in vivo than those used previously that
yielded inconclusive results.
Background
Proteins containing iron-sulfur clusters play essential
roles in electron-transfer, catalysis and other biochem-
ical processes [1,2]. In eubacteria and in many eukar-
yotes, general iron-sulfur cluster biosynthesis is
mediated by the multi-component ISC assembly system.
Extensive biochemical and genetic studies [3-9] have
shown that this process occurs through the assembly of
a cluster on the scaffold protein IscU (Isu in yeast) fol-
lowed by its transfer to a recipient apo-protein. The
efficiency of the second step is greatly increased in the
presence of HscA and HscB (Ssq1 and Jac1, respectively,
in yeast), but the precise role of this chaperone system
is not well understood [9-12].
HscB is a 20 kDa J-type co-chaperone protein that
regulates the ATP hydrolysis activity of HscA and tar-
gets IscU to its substrate-binding domain. The crystal
structures of HscB from Escherichia coli [13], Homo
sapiens [14], and Vibrio cholerae [Osipiuk, Gu, Papa-
zisi, Anderson, and Joachimiak unpublished data, PDB
ID: 3HHO] revealed that the cochaperone has a con-
served structural core that consists of two domains
arranged in an L-shaped fold. The N-terminal J-domain
(residues 1-75) is similar in structure to other J-domain
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84-171) adopts a compact three-helix bundle. Sequence
analysis of HscB homologs identified a series of highly
conserved residues (L92, M93, L96, E97, E100, E104, and
F153 in E. coli HscB) that form an extensive, surface-
exposed patch on one face of the C-terminal domain and
it was hypothesized that this region participates in func-
tionally relevant protein-protein interactions [13].
In the cell, the physiologically relevant interaction of
HscB with IscU is presumed to occur when FeS clusters
are bound to the scaffold protein, e.g., IscU[2Fe2S]
[9-12]. However, HscB interacts with both the apo- and
holo-forms of IscU [19], and because of the instability of
cluster-bound forms of IscU, studies of the HscB-IscU
interaction have employed the apo-protein. The impor-
tance of several conserved residues (corresponding to
L96, R99, E100, D103, E104, and Q107 in E. coli HscB)
was first tested by collectively replacing them with ala-
nines in Saccharomyces cerevisiae Jac1 [20]. The resul-
tant hexa-mutant showed reduced affinity for Isu1 in
vitro, but the authors did not identify specific residues
responsible for this drop in affinity. Moreover, the hexa-
mutant did not produce a growth phenotype in yeast,
which suggested that either the Jac1-Isu1 interaction
was not sufficiently disrupted or that it is not essential
under certain conditions in vivo.
More recently, we used NMR spectroscopy and muta-
genesis techniques to study the E. coli HscB-IscU inter-
action [21]. On the basis of these results, we proposed
that the IscU binding site on HscB consists of the
highly conserved surface patch noted previously plus
nearby residues that either are conserved only in g-pro-
teobacteria(R99, D103, R152, K156, S160) or are not
conserved (R87, T89). Triple alanine substitution of
E97, E100, and E104 resulted in a modest (≅1.2-fold)
decrease in the maximal synergistic stimulation of HscA
by HscB and IscU and also in a modest (≅2-fold)
increase in the concentration of IscU required for half-
maximal stimulation. On the other hand, triple alanine
substitution of L92, M93, and F153 had a much more
detrimental effect: the maximal synergistic stimulation
of HscA by HscB and IscU decreased ≅5-fold, and the
concentration of IscU required for half-maximal stimu-
lation increased ≅8-fold.
These studies left several important questions unan-
swered. Which of the alanine substitutions are responsi-
ble for the detrimental effects reported in our previous
study and are there additional residues that are critical
for the stability of the HscB-IscU complex? Is, in fact,
the HscB-IscU interaction unnecessary under certain
conditions as suggested by the Jac1-Isu1 study? In the
work reported here, we used ITC and NMR spectro-
s c o p yt od e f i n et h ei n d i v i d u al contribution of fourteen
HscB residues to the stability of the HscB-(apo-IscU)
complex. Our results allowed us to refine the residues
of HscB critical for strong interaction with IscU to three
hydrophobic residues (L92, L96, and F153), with a single
negatively charged residue (E100), and two positively
charged residues (R87 and R99) providing additional but
smaller contributions. Moreover, we suggest a pattern of
alanine substitution that could prove useful in testing
the importance of the HscB-IscU interaction in vivo.
Results
Structure and stability of alanine-substituted HscBs
Using the QuikChange technique and previously
described expression and purification procedures
[19,21,22], we generated single alanine substitutions in
E. coli HscB at positions 87, 89, 92, 93, 96, 97, 99, 100,
103, 104, 152, 153, 156, and 160. All of the mutants dis-
played far- and near-UV CD spectra similar to wild-type
HscB (see Additional File 1). In addition, mutants with
an alanine substitution at position 92, 93, 96, 97, 99,
153, or 156 displayed solution molecular masses
(≅29 kDa) and thermal stabilities (Tm≅ 65°C) similar to
wild-type HscB (see Additional Files 2 and 3, respec-
tively). Although HscB(R152A) also displayed a solution
molecular mass ≅29 kDa, it showed a slightly lower
melting temperature (Tm≅ 62°C) than wild-type HscB
(see Additional Files 2 and 3, respectively). Together,
these results suggest that the overall structure, oligo-
meric state, and stability of HscB are not affected to any
significant degree by the single alanine substitutions.
Affinity of alanine-substituted HscBs for IscU
To investigate whether any of the alanine substitutions
perturbed the stability of the HscB-IscU complex, we used
ITC to determine the binding affinity of each alanine
mutant for apo-IscU (Table 1, Figure 1, and Additional
File 4). Under the conditions of the experiment, wild-type
HscB bound IscU with an affinity of 9 ± 2 μMw h i c h
approximates the previously reported value of 13 μM [19].
Alanine substitutions at position 89, 93, 97, 103, 104, 152,
156, or 160 had no or only minor effects on the binding of
HscB to IscU (Kd ≅ 4-17 μM). In contrast, substitutions
R87A (Kd ≅ 36 μM), R99A (Kd ≅ 53 μM), and E100A
(Kd ≅ 42 μM) decreased the affinity of HscB for IscU ≅ 4-
to 6-fold. The most dramatic effects were observed for
three hydrophobic residues in the center of the proposed
IscU binding site. Substitutions L92A (Kd ≅ 200 μM),
L96A (Kd ≅ 200 μM), and F153A (Kd ≅ 200 μM) decreased
the affinity of HscB for IscU greater than 20-fold com-
pared to that of wild-type protein.
To investigate the effect of multiple alanine substitu-
tions on the affinity of HscB for IscU, we also evaluated
by ITC the behaviour of our previously studied triple
alanine mutants. The (E97A, E100A, E104A) substitu-
tion had a modest effect on the binding of HscB to IscU
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observed for the E100A single mutant. In contrast, the
effect of the (L92A, M93A, F153A) substitution was
much greater than the effect of any single alanine sub-
stitution. The heats of injection for this triple mutant
were very small (less than 0.2 kcal/mol), and fitting of
the data to extract binding parameters was unsuccessful.
NMR spectroscopy of alanine-substituted HscB
As an independent means of assessing the effects of the
single alanine substitutions, we used NMR spectroscopy
to compare selected HscB mutants with wild-type HscB.
One representative mutant was chosen from each of the
three types of mutants observed in our ITC studies:
HscB(D103) (little or no effect on affinity of HscB for
IscU), HscB(E100A) (modest effect on affinity of HscB
for IscU), and HscB(L96A) (dramatic effect on affinity of
HscB for IscU). The
15N-HSQC spectra of the free pro-
teins were very similar (see Additional Files 5, 6, 7, 8, 9,
10), and larger chemical shift differences (≅ 0.040 ppm)
were only observed for residues in the immediate vici-
nity of the alanine substitutions (F91-K109). The pre-
sence of a six-fold molar excess of IscU produced larger
chemical shift differences among the
15N-HSQC spectra
of the proteins, but the overall peak pattern of all four
spectra remained very similar (see Additional File 11).
Together, these results indicate that an alanine substitu-
tion at position 96, 100 or 103 does not alter the overall
fold of free HscB to any significant degree and that the
different forms of HscB adopt similar structures in the
HscB-IscU complex.
Next, we recorded a series of
15N-HSQC spectra for
HscB in the presence of varying amounts of apo-IscU.
We observed previously that many of the NMR signals
that map to the IscU binding site on HscB are broad
and unobservable in the HscB-IscU complex [21]. Thus
those HscB signals observed to shift upon addition of
IscU need not all be in the contact region and may sim-
ply report on a conformational transition that accompa-
nies IscU binding. Nevertheless, their chemical shift
changes report on the binding interaction and can be
used to assess binding strength. Therefore, we reasoned
that if a substitution leaves the HscB-IscU binding
Table 1 ITC binding isotherms for the interaction of IscU
with wild-type and alanine-substituted forms of HscB
1
HscB nK a(10
5M
-1) ΔH(kcal/mol) ΔS (e.u.)
wild-type 1.02 ± 0.08 1.16 ± 0.28 -2.22 ± 0.34 15.7 ± 0.7
R87A 1.04 0.28 -0.88 17.4
T89A 1.08 0.59 -1.00 18.4
L92A 0.70 0.05 0.41 18.3
M93A 0.83 ± 0.04 2.55 ± 0.49 -1.25 ± 0.07 20.4 ± 0.1
L96A 0.44 ± 0.04 0.05 ± 0.01 -3.60 ± 0.00 4.8 ± 0.6
E97A 0.96 1.73 -2.60 15.2
R99A 0.69 0.19 1.18 23.6
E100A 0.91 0.24 -2.22 12.0
D103A 1.04 0.54 -1.61 16.2
E104A 0.83 1.72 -2.80 14.6
R152A 1.09 0.65 -1.34 17.5
F153A 0.78 0.05 0.58 19.0
K156A 0.93 2.59 -2.64 15.9
S160A 1.05 0.92 -1.58 17.4
E97A, E100A, E104A 0.68 0.33 -1.73 14.9
1Stoichiometries (n), association constants (Ka), heats of binding (ΔH), and
entropies of binding (ΔS) for the interaction of wild-type and alanine-
substituted forms of HscB with apo-IscU, as determined by ITC. The entropic
contribution was determined from the relationship, ΔGb = ΔHb -T ΔSb, where
ΔGb = -RTlnKa. Owing to the low n values obtained with HscB(L92A), HscB
(L96A), HscB(R99A), HscB(F153A), and HscB(E97A, E100A, E104A), the ΔHa n d
ΔS values determined for these variants are likely only approximate. Gb values
cited in the text were calculated from the relationship, ΔΔGb = ΔGb (mutant
HscB) - ΔGb (wild-type HscB).
Figure 1 ITC data for titration of wild-type or selected alanine-
substituted forms of HscB with apo-IscU. Titrations were
performed in 50 mM HEPES pH 7.5, 150 mM NaCl, 4 mM TCEP at 25
°C. The concentrations of reactants were 0.25-0.4 mM HscB and 2.5-
4 mM apo-IscU. Additional File 4 contains similar data for the
remaining alanine-substituted forms of HscB.
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s i m i l a re x t e n ta ta n yg i v e nH scB/IscU ratio relative to
the wild-type HscB-IscU complex. In turn, this will
cause the progressive IscU-induced chemical shift
changes exhibited by the mutant HscB to be very similar
to those of wild-type HscB. Based on our ITC results,
we hypothesized that HscB(D103A) will show this type
of behaviour. In contrast, if a substitution decreases the
HscB-IscU binding strength, the complex should be
saturated to a smaller extent at any given HscB/IscU
ratio relative to the wild-type HscB-IscU complex. In
turn, this will cause the progressive IscU-induced che-
mical shift changes exhibited by the mutant HscB to be
smaller than those of wild-type HscB. Based on our ITC
results, we hypothesized that HscB(L96A) and HscB
(E100A) will show this type of behaviour.
The
15N-HSQC spectral series for each mutant was
first examined to identify all peaks showing chemical
shift changes during the titration; subsequently, the
observed chemical shift changes were plotted as a func-
tion of IscU/HscB molar ratio, and the results were
compared to those obtained for wild-type HscB. Figure 2
shows examples of such a comparison for three well
resolved peaks in the HSQC spectral series: F77, V133,
and E166. The behaviour of F77 is representative of the
majority of peaks that experienced large chemical shift
changes, while the behaviours of V133 and E166 are
representative of the majority of peaks that experienced
moderate and small chemical shift changes, respectively.
For HscB(D103A), F77, V133, and E166 showed a very
similar pattern of progressive chemical shift changes to
that observed for wild-type HscB (yellow circles versus
black diamonds). This indicates that at any given HscB/
IscU ratio, the complex is similarly saturated whether it
contains wild-type HscB or HscB(D103A). Therefore, an
alanine substitution at position 103 of E. coli HscB
affects the protein’s affinity for IscU only slightly. For
HscB(E100A), the progressive chemical shift changes for
all three residues appeared ≅ 25-50% smaller than for
wild-type HscB at each HscB-IscU molar ratio examined
(green triangles versus black diamonds). This indicates
that at any given HscB/IscU ratio, the complex contain-
ing the mutant is less saturated than that containing the
wild-type protein. Therefore, an alanine substitution at
position 100 of E. coli HscB affects its affinity for IscU
to a greater extent than the D103A substitution. Of the
three alanine substitutions examined, the one at position
96 had the largest effects. The progressive chemical shift
changes for F77, V133, and E166 of HscB(L96A) were
over 50% smaller than for wild-type HscB at each HscB-
IscU molar ratio examined (red squares versus black
diamonds). This indicates that at any given HscB/IscU
ratio, the complex containing the L96A mutant is much
less saturated than that containing the wild-type protein
or either of the other two mutants. Therefore, an ala-
nine substitution at position 96 of E. coli HscB produces
the largest decrease in the affinity of the cochaperone
for IscU.
Figure 3 shows the combined chemical shift changes
observed for all residues of wild-type HscB and of the
Figure 2 NMR data for the titration of [U-
15N]-labeled HscB
with apo-IscU. Combined chemical shift changes (ΔδHN
IscU)o f
selected residues are plotted as a function of IscU/HscB molar ratio
for wild-type HscB (black diamonds), HscB(D103A) (yellow circles),
HscB(E100A) (green triangles), and HscB(L96A) (red squares). ΔδHN
IscU
values are reported as the combination of changes in the proton
(H
IscU) and nitrogen (ΔδN
IscU) dimensions according to ΔδHN
IscU =
[(ΔδH
IscU)
2 + ΔδN
IscU/6)
2]
1/2 [29]. ΔδH
IscU and ΔδN
IscU are calculated
relative to the free form of each protein.
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15N]-labeled HscB in the presence of a six-fold molar excess of apo-IscU. Combined chemical shift changes
(ΔδHN
IscU) are plotted for wild-type HscB (black), HscB(D103A) (yellow), HscB(E100A) (green), and HscB(L96A) (red). ΔδHN
IscU values are reported as
the combination of changes in the proton (ΔδH
IscU) and nitrogen (ΔδN
IscU) dimensions according to ΔδHN
IscU =[ ( ΔδH
IscU)
2 + ΔδN
IscU/6)
2]
1/2 [29].
ΔδH
IscU and ΔδN
IscU are calculated relative to the free form of each protein. Residues whose peaks disappear in the presence of apo-IscU for at
least one form of HscB are marked with an asterisk and are also listed in Additional Files 5 to 8. Values are not shown for residues that have an
unassigned
1H
N-
15N cross-peak in free HscB, that lack an observable
1H-
15N cross-peak in free and/or bound HscB, have an overlapped
1H-
15N
cross-peak in free and/or bound HscB, or are prolines (P10, P33, and P64). The diagram at the top of each panel shows the location of secondary
structural elements in E. coli HscB.
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six-fold molar excess of apo-IscU. The pattern of chemi-
cal shift changes parallels that observed for F77, V133,
and E166: residues of HscB(D103A) behave similarly to
wild-type HscB (yellow versus black bars), residues of
HscB(E100A) show changes that are ≅ 10-25% smaller
than for wild-type HscB (green versus black bars), and
residues of HscB(L96A) show changes that are over 50%
smaller than for wild-type HscB (red versus black bars).
Therefore, these results also support the conclusion that
the D103A substitution has the smallest effect on the
affinity of HscB for IscU whereas the L96A substitution
has the largest effect. Taken together, the NMR results
are fully consistent with the ITC data and confirm that
alanine substitutions at different positions within the
proposed binding site affect the affinity of HscB for IscU
to different degrees.
Discussion
The experiments described herein continue previous
work from our laboratory on the HscB-IscU interaction.
We individually replaced with alanine fourteen surface-
exposed residues in the C-terminal domain of E. coli
HscB, and evaluated their effects using ITC and NMR
spectroscopy. Of the three highly conserved acidic resi-
dues (E97, E100, E104), only the E100A substitution
perturbed the affinity of HscB for IscU (Figure 4). The
resultant change in the free energy of binding (ΔΔGb ≅
0.9 kcal/mol) was close to the experimentally deter-
mined value for a mutant with alanine substitutions at
all three acidic positions, suggesting that the effects of
the substitutions are additive and that the slightly
decreased function of the triple mutant observed in our
previous work [21] is caused predominantly by the
E100A substitution.
By contrast, of the four highly conserved hydrophobic
residues of HscB, three make major contributions to the
stability of the complex with apo-IscU (Figure 4). Ala-
nine substitutions at positions 92, 96, or 153 decreased
t h ea f f i n i t yo fH s c Bf o rI s c U≅ 5-fold more than the
E100A substitution, and resulted in ΔΔGb values of
approximately 1.9 kcal/mol. Although L92, L96, and
F153 appear to be the most important residues, others
(T87, R99, E100) were also found to make substantial
contributions to the stability of the HscB-IscU complex.
On the other hand, substitutions at positions 89, 93, 97,
103,104, 156, and 160 had little or no effect; this sug-
gests that these residues are located at the periphery of
the HscB-IscU interface where additional solvent mole-
cules and the rearrangement of hydrogen bonding pat-
terns can more easily accommodate a missing side chain
[23,24].
Conclusions
The present results explain earlier studies of the triple
mutant, HscB(L92A, M93A, F153A). Of these three substi-
tutions, L92A and F153A are the ones expected to affect
the interaction with IscU, and we can estimate that they
will destabilize the HscB-IscU complex by ≅ 3.7 kcal/mol.
This large effect explains the very small (less than 0.2 kcal/
mol) heats of injection observed in our ITC experiments
(Additional File 4), the low level of HscA stimulation
achieved by this mutant [21], and the weak NMR shifts of
15N-labeled IscU when titrated with this mutant [25].
Our results also suggest a new pattern of alanine sub-
stitution to test the in vivo significance of the HscB-
IscU interaction. If the effect of each substitution is
additive, alanine substitutions at positions 96, 99, 100,
103, 104, and 107 (corresponding to the hexa-alanine
substitution made in Jac1 previously [20]) will destabi-
lize the HscB-IscU complex by ≅ 4.2 kcal/mol, corre-
sponding to a ≅ 1000-fold reduction in the affinity of
HscB for IscU. While this is a large drop in affinity, it
might not be sufficient to completely disrupt the HscB-
IscU interaction which could explain why a growth phe-
notype was not seen for the corresponding Jac1 mutant.
Our data suggest, however, that a triple alanine substitu-
tion at HscB positions 92, 96, and 153 will destabilize
the HscB-IscU complex to a much greater extent (ΔΔGb
≅ 5.7 kcal/mol), corresponding to a ≅ 15000-fold reduc-
tion in affinity of HscB for IscU. This triple alanine sub-
stitution is expected to disrupt the HscB-IscU
interaction more completely than the hexa-alanine sub-
stitution described above and could prove useful for
in vivo testing of the functional significance of the
HscB-IscU interaction.
Figure 4 ITC results mapped onto the crystal structure of E.
coli HscB. Alanine substitution of L92, L96, or F153 (red) had the
most detrimental effects on the affinity of HscB for apo-IscU, while
alanine substitution at positions 87, 99, or 100 (green) resulted in
smaller effects. Alanine substitution at positions 89, 93, 97, 103, 104,
152, 156, or 160 (dark grey) left the affinity of HscB for apo-IscU
unchanged. This image was prepared with PyMol [30].
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Site-directed mutagenesis
Mutations in vectors for expressing mutants of HscB
were generated using the QuikChange technique and
were confirmed by DNA sequencing.
Protein sample preparation
HscB and IscU proteins were made as described pre-
viously [19,21,22]. Briefly, HscB and IscU were
expressed in Escherichia coli grown in TB media or in
M9 minimal media containing
15NH4Cl. To extract
and purify HscB, cells were lysed by sonication in
TED buffer (50 mM Tris-HCl, pH 7.4, 1 mM DTT,
0.5 mM EDTA) and the soluble fraction was applied
to a room temperature DEAE-cellulose column (DE-
52; Whatman). HscB was eluted using a linear gradi-
ent from 1 to 100 mM NaCl, followed by an isocratic
elution with 100 mM NaCl. Fractions found to con-
tain HscB were pooled, concentrated, and further frac-
tionated using size exclusion chromatography.
Homogeneous fractions of HscB were pooled, concen-
trated, frozen in liquid nitrogen, and stored at 80 °C.
To extract and purify IscU, cells were lysed by sonica-
tion in TED8 buffer (50 mM Tris-HCl, pH 8, 1 mM
DTT, 0.5 mM EDTA) and the soluble fraction was
purified at 4 °C by ion-exchange chromatography with
DEAE-cellulose, DEAE-Biogel (Bio-Rad), and elution
gradients of 0 to 150 mM NaCl. Fractions found to
contain IscU were pooled, concentrated, and further
fractionated at room temperature using size exclusion
chromatography. Homogeneous fractions of IscU were
pooled, concentrated, frozen in liquid nitrogen, and
stored at 80 °C.
Molecular mass determination
The molecular size of wild-type and alanine-substituted
HscBs was estimated by calibrated gel filtration. Chroma-
tography was carried out at 15 °C using a BioSep-SEC-S
2000 column (Phenomenex) connected to a Shimadzu
UFLC system. The column was first equilibrated in
50 mM Tris-HCl pH 7.6, 150 mM NaCl; subsequently a
1 μL aliquot of sample was applied and eluted using the
same buffer. Total protein concentration for all injected
samples was ≅ 1 mg/mL. Standards used included ferritin
(440 kDa), ovalbumin (43 kDa), carbonic anhydrase
(29 kDa), and aprotinin (6.5 kDa). All samples were pre-
pared in equilibration buffer. Kave values were calculated
according to Kave =( Ve - Vo)/( Vc - Vo), where Vo is the
column void volume as determined with Blue Dextran,
Vc is the geometric column volume and Ve is the elution
volume of the molecule under consideration. All runs
were carried out in duplicate.
CD spectroscopy
CD studies were performed on an AVIV 202SF Stopped
Flow Circular Dichroism Spectrometer equipped with a
multi-cell holder. Far-UV spectra were collected from
195 to 300 nm in 1 nm increments with an averaging
t i m eo f5s ,a n du s e d≅ 7 μM protein in 20 mM Tris-
H2SO4 pH 8.0 buffer and a 1 mm path length cell.
Near-UV spectra were collected from 250 to 340 nm in
0.5 increments with an averaging time of 10 s, and
used≅ 41 μM protein in 20 mM Tris-HCl pH 7.9,
1 mM DTT buffer and a 10 mm path length cell. All
spectra were collected at 25 °C and represent a single
scan with the buffer baseline subtracted.
Temperature-induced unfolding of wild-type and ala-
nine-substituted forms of HscB were carried out on
samples containing ≅ 8 μM protein in 50 mM sodium
phosphate pH 7.5 buffer, and were monitored at
200 nm, 208 nm, and 222 nm in a 1 mm path length
cell. The temperature was cycled from 25 °C to 85 °C in
increments of 3 °C. Prior to taking a reading, a 5 minute
thermal equilibration period was established at each
newly set temperature. Once data acquisition at 85 °C
was complete, samples were cooled to 25 °C and a far-
UV spectrum was collected for each. The pre- and post-
melt spectra were almost identical for every mutant
examined, indicating reversibility of unfolding. Dena-
turation profiles were analyzed by a nonlinear least-
squares fit assuming a two state model [26] and with
ΔCp fixed at 0. Resultant Tm and ΔHm values were aver-
aged over the three wavelengths at which data were col-
lected as well as over a duplicate set of experiments.
ITC
ITC measurements were carried out using a VP-ITC
isothermal titration calorimeter (MicroCal LLC). Titra-
tions were performed at 25 °C in 50 mM HEPES pH
7.5, 150 mM NaCl, 4 mM TCEP. Samples contained
0.25-0.4 mM HscB (sample cell) and 2.5-4 mM apo-
IscU (injection syringe). Solutions were thoroughly
degassed by stirring under a vacuum before use. Each
titration was started with an initial injection of 3 μL, fol-
l o w e db y3 4i n j e c t i o n so f8μLw i t ha2 4 0s e c o n dg a p
between consecutive injections. The peaks of the
obtained thermograms were integrated using the ORI-
GIN software supplied with the instrument. A nonlinear
regression fit to each isotherm was performed using the
ORIGIN data analysis routine, yielding binding con-
stants (Ka), enthalpies of binding (ΔH), and stoichiome-
try (n). Data points from the first injections were
normally removed prior to the fitting process. Heat pro-
duced upon injection of buffer into buffer was small
(less than 0.2 kcal/mol), and the data presented in the
Füzéry et al. BMC Biochemistry 2011, 12:3
http://www.biomedcentral.com/1471-2091/12/3
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except those involving HscB(L92A), HscB(L96A), HscB
(R99A), and HscB(F153A), the heat of dilution of apo-
IscU was approximated using the heats of the last few
injections. For HscB(L92A), HscB(L96A), HscB(R99A),
and HscB(F153A), saturation did not appear to be com-
plete by the end of the experiment. Therefore, the heat
of dilution of apo-IscU was obtained from a separate
experiment in which apo-IscU was titrated into buffer
using the injection schedule described above. Errors
from the fitting procedure were always smaller than
0.04 (n), 0.50 (Ka), and 0.40 (ΔH). All experiments were
performed once except for wild-type HscB (three repeti-
tions), HscB(M93A) (two repetitions), and HscB(L96A)
(two repetitions). Average values and standard devia-
tions are provided for these three forms of HscB.
NMR spectroscopy
Samples for chemical shift perturbation studies contained
0.2 mM [U-
15N]-HscB and varying concentrations of
unlabelled apo-IscU (0 mM, 0.05 mM, 0.1 mM, 0.2 mM,
0 . 4m M ,0 . 8m M ,o r1 . 2m M )i n2 0m MT r i s - H C lp H
7.5, 10 mM DTT, 0.1 mM DSS, and 7 % D2O. A 2D
15N-HSQC was recorded for each sample at 40 °C on a
Bruker DMX-750 Avance spectrometer equipped with a
z-axis gradient cryoprobe. All spectra were processed
with NMRPipe [27] and analyzed with Sparky [28].
Amide
1Ha n d
15N resonances for the mutant proteins
were assigned with the help of our previously determined
assignments for wild-type HscB [21]. Changes in amide
peak positions of HscB as a result of the alanine substitu-
tions, ΔδHN
Ala (in ppm), are reported as a combination of
the changes in the proton (ΔδH
Ala) and nitrogen (ΔδN
Ala)
dimensions according to Eq. 1 [29].
Δ= +  HN
Ala
H
Ala 2
N
Ala 2 1 2 /6 [( ) ( ) ]
/ ΔΔ (1)
Apo-IscU-induced changes in the amide peak position
of HscB, ΔδHN
IscU, were also calculated according to
Eq. 1 but using ΔδH
IscU and ΔδN
IscU instead of ΔδH
Ala
and ΔδN
Ala.
Additional material
Additional File 1: Far-UV and near-UV CD spectra of wild-type and
alanine-substituted forms of HscB.
Additional File 2: Apparent molecular masses of wild-type and
selected alanine-substituted forms of HscB, as determined by
analytical gel filtration.
Additional File 3: Transition parameters for the thermal
denaturation of wild-type and selected alanine-substituted forms
HscB.
Additional File 4: Representative ITC binding isotherms for the
interaction of IscU with wild-type and alanine-substituted forms of
HscBTitrations were performed in 50 mM HEPES pH 7.5, 150 mM NaCl, 4
mM TCEP at 25 °C. The concentrations of reactants were 0.25-0.4 mM
HscB (cell) and 2.5-4 mM apo-IscU (injection syringe).
Additional File 5:
15N-HSQC spectra of wild-type HscB, HscB(D103A),
HscB(E100A), and HscB(L96A)Samples contained 0.2 mM [U-
15N]-HscB
in 20 mM Tris-HCl pH 7.5, 10 mM DTT, 0.1 mM DSS, and 7 % D2O. Each
spectrum was recorded at 40 °C on a Bruker DMX-750 Avance
spectrometer equipped with a z-axis gradient cryoprobe. Peaks that are
folded into the spectrum are colored in magenta.
Additional File 6: Chemical shift assignments for free and IscU-
bound wild-type HscB
1H( δH) and
15N( δN) chemical shifts (in ppm) of
assigned peaks in the
15N-HSQC spectrum of unbound HscB, and HscB in
the presence of a six-fold molar excess of IscU ("IscU-bound HscB”).
Additional File 7: Chemical shift assignments for free and IscU-
bound HscB(D103A)
1H( δH) and
15N( δN) chemical shifts (in ppm) of
assigned peaks in the
15N-HSQC spectrum of unbound HscB(D103A), and
HscB(D103A) in the presence of a six-fold molar excess of IscU ["IscU-
bound HscB(D103A)"].
Additional File 8: Chemical shift assignments for free and IscU-
bound HscB(E100A)
1H( δH) and
15N( δN) chemical shifts (in ppm) of
assigned peaks in the
15N-HSQC spectrum of unbound HscB(E100A), and
HscB(E100A) in the presence of a six-fold molar excess of IscU ["IscU-
bound HscB(E100A)"].
Additional File 9: Chemical shift assignments for free and IscU-
bound HscB(L96A)
1H( δH) and
15N( δN) chemical shifts (in ppm) of
assigned peaks in the
15N-HSQC spectrum of unbound HscB(L96A), and
HscB(L96A) in the presence of a six-fold molar excess of IscU ["IscU-
bound HscB(L96A)"].
Additional File 10: Combined chemical shift changes of free HscB
(D103A), HscB(E100A), and HscB(L96A) relative to wild-type
HscBCombined chemical shift changes are reported as the combination
of changes in the proton (ΔδH
Ala) and nitrogen (ΔδN
Ala) dimensions
according to ΔδHN
Ala =[ ( ΔδH
Ala)
2 + ΔδN
Ala/6)
2]
1/2 [29].
Additional File 11:
15N-HSQC spectra of wild-type HscB, HscB
(D103A), HscB(E100A), and HscB(L96A) in the presence of a six-fold
molar excess of IscUSamples contained 0.2 mM [U-
15N]-HscB and 1.2
mM IscU in 20 mM Tris-HCl pH 7.5, 10 mM DTT, 0.1 mM DSS, and 7 %
D2O. Each spectrum was recorded at 40°C on a Bruker DMX-750 Avance
spectrometer equipped with a z-axis gradient cryoprobe. Peaks that are
folded into the spectrum are colored in magenta.
List of abbreviations used
NMR: nuclear magnetic resonance; ITC: isothermal titration calorimetry; CD:
circular dichroism; [U-
15N], uniformly
15N-labeled.
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